CJC-1295 & GHRP-6 Blend
A research blend combining CJC-1295 (Mod GRF 1-29) with GHRP-6 for synergistic GH release paired with GHRP-6's notable appetite-stimulating effect.
Community Rating
No ratings yet
Compound Profile
CJC-1295 & GHRP-6 Blend
Key Data
Research reference only
Research Focus
Preclinical data
⚠ Research & Educational Use Only. CJC-1295 & GHRP-6 Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Synergistic GH release via dual-receptor mechanism
- GHRP-6 appetite stimulation useful in caloric surplus research
- Strong GH pulse amplitude
- CJC-1295 & GHRP-6 Blend is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Synergistic GH release via dual-receptor mechanism
- GHRP-6 appetite stimulation useful in caloric surplus research
- Strong GH pulse amplitude
- Widely used combination in GH research protocols
In Plain English
Simple summaryCJC-1295 + GHRP-6 combines long-acting sustained GHRH stimulation with GHRP-6's ghrelin-like appetite-stimulating profile. The sustained GH elevation from CJC-1295-DAC combined with GHRP-6's strong hunger drive creates a protocol profile that's specifically relevant for research targets involving both increased GH and increased caloric intake -- such as muscle-building or recovery research contexts where driving a positive caloric environment is part of the research design.
- Synergistic GH release via dual-receptor mechanism
- GHRP-6 appetite stimulation useful in caloric surplus research
- Strong GH pulse amplitude
The full scientific detail, mechanisms, citations, and dosing data, follows below.
What is CJC-1295 & GHRP-6 Blend?
Tap any underlined term for an instant definition.
CJC-1295 & GHRP-6 Blend pairs CJC-1295 (no DAC / Mod GRF 1-29) with GHRP-6. This combination mirrors the Mod GRF 1-29 + GHRP-6 protocol and is particularly relevant for research examining the interaction between GH axis stimulation and appetite/caloric intake, given GHRP-6's strong motilin-receptor-mediated appetite effect.
What It Is
- CJC-1295 (no DAC): GHRH receptor agonist
- GHRP-6: GHS-R1a + motilin receptor agonist with pronounced appetite-stimulating properties
- Research application: studying combined GH + appetite effects; also used in mass-gaining body composition protocols
How It Works
- GHRHR activation from CJC-1295 + GHS-R1a stimulation and somatostatin suppression from GHRP-6
- Motilin receptor binding from GHRP-6 drives gastric motility and ghrelin-like appetite stimulation
- GH pulses: 3-4x either peptide alone
- Appetite stimulation onset: 20-40 minutes post-injection; duration 1-2 hours
Key Research Findings
- GH response comparable to other GHRH + GHRP combinations
- Appetite: Reliable caloric intake increase in research subjects; useful when caloric surplus is required
- Lean mass: Strong gains when GHRP-6's appetite effect supports adequate caloric intake
Dosing From the Literature
- CJC-1295 (no DAC) 100-200 mcg + GHRP-6 100-200 mcg per injection
- Twice daily; administer before anticipated meals
Storage and Handling
- Lyophilised: 2-8 degrees C; 24 months
- Reconstituted: 2-8 degrees C; use within 30 days
By the Numbers
Key Research Benefits
Documented effects observed in preclinical and clinical studies on CJC-1295 & GHRP-6 Blend. See all Peptide Blends peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Subcutaneous injection. Time GHRP-6 injection before meals if appetite stimulation is desired endpoint.
What the research doesn't show
The hunger effect of GHRP-6 is not subtle -- it's a consistent, notable increase in appetite that occurs within minutes of dosing. In research contexts where caloric intake is a controlled variable, GHRP-6's appetite effect is a significant confound. In practice, many protocols that list GHRP-6 are used specifically for this appetite-stimulating property alongside GH.
Medical Expert Videos
Physicians, researchers, and pharmacologists explain CJC-1295 & GHRP-6 Blend, covering mechanisms of action, clinical context, and study findings.
Videos sourced from YouTube search. KnowYourPeptide does not endorse any individual creator. For research education only.
The Bottom Line
CJC-1295 & GHRP-6 Blend has a growing body of preclinical evidence and a well-characterised safety profile in research settings. The most-studied application is: synergistic gh release via dual-receptor mechanism.
The most commonly reported side effect in research subjects is pronounced appetite stimulation. It is a research chemical, not approved for human use.
Frequently Asked Questions
Explore Further
Quick Reference
More in Peptide Blends
- Sermorelin & Ipamorelin Blend
- Sermorelin & GHRP-2 Blend
- Sermorelin & GHRP-6 Blend
- Sermorelin & GHRP-6 & GHRP-2 Triple Blend
How It Compares
CJC-1295 + Ipamorelin achieves the sustained GH profile without the appetite drive. CJC-1295 + GHRP-2 offers similar potency with less appetite stimulation but more cortisol. GHRP-6 is uniquely appetite-stimulating -- if the research goal doesn't require hunger stimulation, ipamorelin is the preferred GHRP partner.
Compare CJC-1295 & GHRP-6 Blend side-by-sideResearch Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.